ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans

被引:34
作者
Al-Majed, HT
Jones, PM
Persaud, SJ
Sugden, D
Huang, GC
Amiel, S
Whitehouse, BJ
机构
[1] Kings Coll London, Ctr Reprod Endocrinol & Diabet, GKT Sch Biomed Sci, London SE1 1UL, England
[2] GKT Sch Med, London SE5 9PJ, England
关键词
D O I
10.1677/joe.0.1800155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has previously been suggested that ACTH and ACTH-related peptides may act as paracrine modulators of insulin secretion in the islets of Langerhans. We have, therefore, examined the expression and function of the ACTH receptor (the melanocortin 2 receptor, MC2-R) in human and mouse primary islet tissue and in the MIN6 mouse insulinoma cell line. Mouse MC2-R mRNA was detected in both MIN6 cells and mouse islet tissue by PCR amplification of cDNA. In perifusion experiments with MIN6 pseudo-islets, a small, transient increase in insulin secretion was obtained when ACTH(1-24) (1 nM) was added to medium containing 2 mM glucose (control) but not when the medium glucose content was increased to 8 mM. Further investigations were performed using static incubations of MIN6 cell monolayers; ACTH(1-24) (1 pM-10 nM) provoked a concentration-dependent increase in insulin secretion from MIN6 monolayer cells that achieved statistical significance at concentrations of 1 and 10 nM (150 +/- 13.6% basal secretion; 187 +/- 14.9% basal secretion, P < 0.01). Similar responses were obtained with ACTH(1-39). The phosphodiesterase inhibitor IBMX (100 muM) potentiated the responses to sub-maximal doses of ACTH(1-24). Two inhibitors of the protein kinase A (PKA) signaling pathway, Rp-cAMPS (500 muM) and H-89 (10 muM), abolished the insulin secretory response to ACTH(1-24) (0.5-10 nM). Treatment with 1 nM ACTH(1-24) caused a small, statistically significant increase in intracellular cAMP levels. Secretory responses of MIN6 cells to ACTH(1-14) were also influenced by changes in extracellular Ca2+ levels. Incubation in Ca2+-free buffer supplemented with 0.1 mM EGTA blocked the MIN6 cells' secretory response to I and 10 nM ACTH(1-24). Similar results were obtained when a Ca2+ channel blocker (nitrendipine, 10 muM) was added to the Ca2+ containing buffer. ACTH(1-24) also evoked an insulin secretory response from primary tissues. The addition of ACTH(1-24) (0.5 nM) to perifusions of mouse islets induced a transient increase in insulin secretion at 8 mM glucose. Perifused human primary islets also showed a secretory response to ACTH(1-24) at basal glucose concentration (2 mM) with a rapid initial spike in insulin secretion followed by a decline to basal levels. Overall the results demonstrate that the MC2-R is expressed in beta-cells and suggest that activation of the receptor by ACTH initiates insulin secretion through the activation of PKA in association with Ca2+ influx into beta-cells.
引用
收藏
页码:155 / 166
页数:12
相关论文
共 58 条
[1]   Autonomic regulation of islet hormone secretion -: Implications for health and disease [J].
Ahrén, B .
DIABETOLOGIA, 2000, 43 (04) :393-410
[2]  
ASHCROFT FM, 1992, INSULIN MOL BIOL PAT, P97
[3]   STEROIDOGENIC ACTIVITY OF HIGHLY POTENT MELANOTROPIC PEPTIDES IN THE ADRENAL-CORTEX OF THE RAT [J].
BAUMANN, JB ;
EBERLE, AN ;
CHRISTEN, E ;
RUCH, W ;
GIRARD, J .
ACTA ENDOCRINOLOGICA, 1986, 113 (03) :396-402
[4]   GLUCOSE-INDUCED SECRETION OF ACTH-LIKE PRODUCTS BY RAT PANCREATIC-ISLETS [J].
BORELLI, MI ;
MORANO, MI ;
ESTIVARIZ, FE ;
GAGLIARDINO, JJ .
ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1994, 102 (01) :17-20
[5]   Evidence for the paracrine action of islet-derived corticotropin-like peptides on the regulation of insulin release [J].
Borelli, MI ;
Estivariz, FE ;
Gagliardino, JJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (05) :565-570
[6]   Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line [J].
Boston, BA ;
Cone, RD .
ENDOCRINOLOGY, 1996, 137 (05) :2043-2050
[7]  
BOTELHO LHP, 1988, METHOD ENZYMOL, V159, P159
[8]   Serum cortisol and 17-hydroxyprogesgterone interrelation in classic 21-hydroxylase deficiency: Is current replacement therapy satisfactory? [J].
Charmandari, E ;
Matthews, DR ;
Johnston, A ;
Brook, CGD ;
Hindmarsh, PC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4679-4685
[9]  
CHIJIWA T, 1990, J BIOL CHEM, V265, P5267
[10]   DYNAMICS OF INSULIN RELEASE BY PERFUSED RAT PANCREASES - EFFECTS OF HYPOPHYSECTOMY, GROWTH-HORMONE, ADRENOCORTICOTROPIC HORMONE AND HYDROCORTISONE [J].
CURRY, DL ;
BENNETT, LL .
ENDOCRINOLOGY, 1973, 93 (03) :602-609